Johnson & Johnson Innovation — JJDC takes equity stake in Triastek
Johnson & Johnson Innovation-JJDC will make an equity investment in Triastek under a strategic oral medicines collaboration. The deal pairs Johnson & Johnson drug development capabilities with Triastek’s 3D printing technology for oral delivery of peptides. The companies entered a Collaboration and License Agreement th